Mannitol Injection 20% 250ml Plastic Bottle

• Medicine: Large Volume Injection
• Transport Package: Carton
• Specification: 250ml
• Trademark: SHIMEN
• Origin: Hebei
• Model NO.: 250ml
• HS Code: 3004909099
• Production Capacity: 1000000

Product Description

Mannitol Injection 20%
 

Name: Mannitol Injection
Main ingredients: D-Mannitol
Structural formula : C₆H₁₄O₆
Mol wt: 182.17
Description The product is clear colorless liquid.


Action and usage:
(1)Dehydration drug. It can be used for the treatment of cerebral edema, decreasing the intracranial pressure, and the prevention of cerebral hernia.
(2)Decrease the intra-ocular pressure. The product can be used when there is any effect with other medicine or used for the preparation of eye surgery.
(3) Osmotic diuretic. Used to identify oliguresis caused by all kinds of factors, also used for the prevention of acute renal tububle necroses.
(4) Used to treat the renal disease syndrome, ascites due to cirrhosis as the auxiliary hydragog.
(5) For the overdose or toxicosis of some medicine, such as barbital, lithium, salicylate and bromide, the product can promote the excretion of the aforementioned and prevent the renal toxicity.
(6) Used as irrigation when the patient is made prostate excision surgery through the urethra.
(7) Before the surgery make the intestinal canal preparation. 

Shijiazhuang No. 4 Pharmaceutical Co., Ltd., as one of the leading manufacturers in Chinese pharmaceutical industry and a well-known brand, has a business history of seventy years. The company principally specializes in R & D, manufacture and sales of wide types of drugs mainly including intravenous infusion.
The production lines have achieved full automation control and information control in the production process and logistics process and reached international advanced level by integrating the world's leading equipment and technology.
With product quality as its life, the Company always organizes production in strict accordance with GMP requirements, establishes and implements superior service concepts and measures and provides guarantee for the health of the majority of patients at home and abroad with excellent quality products and services.
The Company has a powerful R&D team and made a number of achievements in scientific research and undertaken many major scientific and technological innovation projects and industrialization projects by firmly grasping the pulse of pharmaceutical development, increasing new product development investment and accelerating the pace of technological innovation.
Large volume injection is the key products, tablets, capsules, small volume injection and other forms are manufactured also. Recently API has been put into production and sales. There are more than ten international advanced production lines for the large volume injection, its production scale, technology level, brand influence and economic benefit are on the forefront of domestic counterparts, and it has become one of China's top 100 pharmaceutical industry enterprises and China's top 10 chemical and pharmaceutical industry preparation export-oriented excellent enterprise brands for many consecutive years.
The products are radiated to all provinces, autonomous regions and municipalities in China and also exported to many overseas markets, including more than 80 countries in Asia, Americas, Europe, Oceania, Africa and other continents, and it has become one of the main export enterprises of infusion products.